February 14, 2023
A proposed class of CBD supplement buyers is again asking a California federal court to reopen its claims alleging CV Sciences Inc. illegally sold CBD products as dietary supplements, saying a recent announcement from the U.S. Food and Drug Administration means there's no reason for further delay.
August 18, 2022
A proposed class of CBD supplement buyers is asking a California federal court to let their claims alleging that CV Sciences Inc. illegally sold the products move forward, while the company is arguing that a stay in the case, which is pending U.S. Food and Drug Administration action, should remain in place.
December 07, 2020
A proposed class action against CBD company CV Sciences will remain paused in California federal court until regulators come around to issuing guidelines on how the popular hemp-derived compound can be marketed in edible products.
December 01, 2020
Consumers suing CBD company CV Sciences urged a California federal judge Tuesday to allow their lawsuit to move forward, arguing that waiting for the U.S. Food and Drug Administration to issue regulations on CBD won't negate their claims.
September 02, 2020
A proposed class of consumers whose action against CBD company CV Sciences has been paused told a California federal judge that recent comments from the U.S. Food and Drug Administration regarding CBD products make it appropriate to lift the stay.
May 26, 2020
A California federal court has paused a proposed class action accusing a CBD company of hawking products that aren't compliant with U.S. Food and Drug Administration guidelines, saying the case should wait until the agency unveils new cannabinoid regulations.
February 07, 2020
A CBD seller has urged a California federal court to toss a proposed class action accusing it of hawking products that aren't compliant with U.S. Food and Drug Administration guidelines, arguing that the consumers are trying to co-opt the federal government's enforcement power.
December 03, 2019
Two more CBD companies are facing proposed class actions by consumers who say they would not have purchased their products if they had known they were not compliant with U.S. Food and Drug Administration guidelines.